Among the patients with primary iCCA, the most common genomic alterations were BAP1 (20.6%), TP53 (20.4%), IDH1 (19.0%), FGFR2 (18.1%), and CDKN2A (17.3%). This evidence concerns the gene CDKN2A and infantile convulsions and choreoathetosis.